Irisin Expression and Gene Polymorphism With Peripartum Cardiomyopathy.

Peripartum Cardiomyopathy Clinical Trial

Official title:

FDNC5 Genetic Polymorphism in Patients With Peripartum Cardiomyopathy

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04927715
• Other study ID #: Soh-Med-21-02-26
• Status: Recruiting
• Start date: February 20, 2021
• Est. completion date: February 28, 2022

Study information

• Verified date: January 2022
• Source: Sohag University
• Contact: Ali mo Altaher, lecturer
• Phone: 01003376529
• Email: dr.ali.altaher30[@]gmail.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

this is an observertional study aimed at Study the association between the level of irisin expression and (Fibronectin Type III Domain Containing 5 (FDNC5) gene polymorphism in female patients with peripartum cardiomyopathy.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 45
• Est. completion date: February 28, 2022
• Est. primary completion date: January 30, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria:

• This study will include females aged between 18 and 45 years old who have been diagnosed and treated clinically for peripartum cardiomyopathy

Exclusion Criteria:

• Age less than 18 or more than 45 year old

• females with dilated cardiomyopathy due to other etiology or outside the time frame of occurrence of peripartum cardiomyopathy

Related Conditions & MeSH terms

• Cardiomyopathies
• Peripartum Cardiomyopathy

Locations

Country	Name	City	State
Egypt	Sohag uniersity hosoital	Sohag

Sponsors (1)

Lead Sponsor	Collaborator
Sohag University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Irisin level	detect the serum level of irisin hormone by ELIZA in nanogram/decilitre(ng/dl)	4 months
Primary	FNDC5 Genotyping	whether homogenetic or heterogenetic	4 months